Hubbry Logo
HemidesmosomeHemidesmosomeMain
Open search
Hemidesmosome
Community hub
Hemidesmosome
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Hemidesmosome
Hemidesmosome
Hemidesmosome
View on Wikipedia
from Wikipedia
Hemidesmosome
Ultrastructure of tracheal hemidesmosomes in mice. In a normal mouse (a) there are well-defined, organized hemidesmosomes with darkened areas in the lamina densa abutting the hemidesmosome (arrows). In contrast, hemidesmosomes in Lamc2 -/- tracheas (b) are less organized, the intracellular component is more diffuse, and the lamina densa directly below the hemidesmosomal areas lacks the electron density seen in the littermate control (arrows). From Nguyen et al., 2006.[1]
Details
Identifiers
Latinhemidesmosoma
MeSHD022002
THH1.00.01.1.02029
FMA67415
Anatomical terminology

Hemidesmosomes are very small stud-like structures found in keratinocytes of the epidermis of skin that attach to the extracellular matrix. They are similar in form to desmosomes when visualized by electron microscopy; however, desmosomes attach to adjacent cells. Hemidesmosomes are also comparable to focal adhesions, as they both attach cells to the extracellular matrix. Instead of desmogleins and desmocollins in the extracellular space, hemidesmosomes utilize integrins. Hemidesmosomes are found in epithelial cells connecting the basal epithelial cells to the basement membrane.[2] Hemidesmosomes are also involved in signaling pathways, such as keratinocyte migration or carcinoma cell intrusion.[3]

Structure

[edit]

Hemidesmosomes can be categorized into two types based on their protein constituents. Type 1 hemidesmosomes are found in stratified and pseudo-stratified epithelium. Type 1 hemidesmosomes have five main elements: integrin α6β4, plectin in its isoform 1a, i. e. P1a, tetraspanin protein CD151, BPAG1e, or bullous pemphigoid antigen isoform e, and BPAG2 (also known as BP180 or type 17 collagen).[2] Type 1 hemidesmosomes are found in stratified and pseudostratified epithelial tissue. Type 2 hemidesmosomes contain integrin α6β4 and plectin without the BP antigens.[4]

Hemidesmosomes have two membrane-spanning components: Integrin α6β4 and BPAG2. Integrin α6β4 operates as a laminin-332 receptor. Integrin α6β4 is composed to two α and β subunit dimers. The larger β4 subunit has domains that bind to fibronectin III and calcium. The α6 subunit binds to extracellular BP180, CD151 and laminin-322. When integrin α6β4 binds to Plectin 1a and BPAG1, it associates with the keratin intermediate filaments in the cytoskeleton.[2]

Hemidesmosomes are linked to keratin by plectin isoform 1a from the plakin protein family. Plectin is a 500 kDa protein with a long, rod-like domain and a domain at the end that contains an intermediate filament binding site. BPAG2, or (bullous pemphigoid antigen 2), is a transmembrane protein that exists adjacent to integrins, BPAG2 has domains that bind to plectin, integrin β4 subunit in the cytoplasm and integrin α6 and laminin-332 in the extracellular space. CD151, a protein of the tetraspanin superfamily, resides on the cell surface of keratinocytes and vascular endothelium. CD151 aids in hemidesmosome formation. BPAG1e is an antigen with multiple isoforms that binds to integrin α6β4, BPAG2 and keratin 5 and 14. The main role of BPAG1e is for hemidesmosome stability.[2]

Diseases

[edit]

Keeping the basal epidermal keratinocytes attached to the basal lamina is vital for skin homeostasis. Genetic or acquired diseases that cause disruption of hemidesmosome components can lead to skin blistering disorders between different layers of the skin. These are collectively coined epidermolysis bullosa, or EB. Typical symptoms include fragile skin, blister development, and erosion from minor physical stress.[2] However, the disease also can manifest as erosions on the cornea, trachea, gastrointestinal tract, esophagus, muscular dystrophy and muscular deformity.[5]

Mutations in 12 different genes that code for parts of the hemidesmosome have led to epidermolysis bullosa.[6] There are three types of EB: EB simplex (EBS), dystrophic EB (DEB) and junctional EB (JEB). In epidermolysis bullosa simplex, layers of the epidermis separate. EBS is caused by mutations coding for keratin, plectin and BPAG1e. With junctional epidermolysis bullosa, layers of the lamina lucida (part of the basal lamina) separate. This is caused by mutations in integrin α6β4, laminin 322 and BPAG2. In dystrophic epidermolysis bullosa, the layers of the papillary dermis separate from the anchoring fibrils. This is caused by mutations in the collagen 7 gene.

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Hemidesmosome

View on Grokipedia
from Grokipedia
Hemidesmosomes are specialized multiprotein adhesion complexes that anchor basal epithelial cells to the underlying , linking the intracellular to the for stable tissue attachment. These structures are essential in stratified and complex epithelia, such as the skin , where they provide mechanical stability against shear forces and maintain epithelial integrity. Structurally, hemidesmosomes exhibit a tripartite organization visible under electron microscopy, consisting of an inner cytoplasmic plaque, a sub-basal dense plate, and an outer attachment zone that extends into the basement membrane's lamina lucida and lamina densa. They are classified into two types: type I hemidesmosomes, predominant in stratified epithelia like the , and type II, found in simple epithelia such as the intestine. Key molecular components include the transmembrane integrin , which binds to laminin-332 in the ; the cytoskeletal linker plectin (isoform 1a); the plakin BPAG1-e (also known as BP230 or DST); the collagen (COL17A1 or BP180); and the tetraspanin , which stabilizes the complex. Assembly begins with recruitment to the plasma membrane, followed by binding to plectin and subsequent incorporation of other proteins to form mature plaques. Beyond adhesion, hemidesmosomes play dynamic roles in epithelial homeostasis, including regulation of pathways such as PI3K/Akt and ERK/MAPK, which influence proliferation, migration, and survival. They disassemble during processes like keratinocyte differentiation, , and tissue remodeling, allowing cell motility while reassembling to restore anchorage. In mechanotransduction, hemidesmosomes modulate traction forces generated at focal adhesions by integrating with the actin cytoskeleton via plectin, thereby influencing cellular mechanics and YAP/TAZ signaling for tissue stiffness sensing. Dysfunction in hemidesmosomes is implicated in hereditary blistering disorders, particularly various forms of epidermolysis bullosa (EB), where mutations in genes encoding core components like ITGA6, ITGB4 (for α6β4), PLEC (plectin), DST (BPAG1), or COL17A1 (BPAG2) lead to skin fragility, blistering, and potential extracutaneous involvement in respiratory or gastrointestinal tracts. Additionally, aberrant hemidesmosome dynamics contribute to pathological conditions such as (an autoimmune disorder targeting BP180 and BP230) and tumor invasion in squamous cell carcinomas, where upregulated α6β4 signaling promotes malignancy.

Overview

Definition

Hemidesmosomes are specialized complexes that mediate strong adhesion between the basal surface of epithelial cells and the underlying , primarily in stratified and pseudostratified epithelia. These structures anchor basal epithelial cells, such as , to the , ensuring stable attachment in tissues like the . Unlike cell-cell junctions, hemidesmosomes form cell-matrix connections that resemble half of a , contributing to the mechanical integrity of epithelial layers. Under electron microscopy, hemidesmosomes appear as electron-dense plaques along the basal plasma membrane of epithelial cells, typically measuring less than 0.5 μm in diameter. The term "hemidesmosome" originates from the Greek "hemi-" (half) and "desmos" (bond), reflecting their role as unilateral adhesion sites compared to bilateral cell-cell desmosomes. These plaques facilitate the insertion of cytoskeletal elements, enhancing tissue stability against mechanical stress.

Biological Significance

Hemidesmosomes are essential for securing basal epithelial cells to the , providing stable anchorage that preserves epithelial integrity across various tissues. This attachment is critical in mechanically stressed environments, such as the skin and mucosal surfaces, where hemidesmosomes link the to the , thereby resisting shear forces and preventing tissue detachment during everyday physiological activities. These structures exhibit tissue-specific adaptations that align with functional demands. In stratified squamous epithelia, including the , hemidesmosomes form type I complexes with multiple components for enhanced durability under constant abrasion and tension. Conversely, in glandular epithelia like the , type II hemidesmosomes predominate, featuring a simplified composition that supports secretory functions and cellular rearrangements without compromising to the . Beyond static support, hemidesmosomes dynamically participate in tissue morphogenesis and repair processes. During embryonic development, their regulated assembly aids in epithelial barrier formation and organ shaping, as seen in branching morphogenesis of glandular tissues where hemidesmosome-mediated adhesion guides and polarization. In adult , hemidesmosomes disassemble at injury sites to enable motility across provisional matrices, then reassemble post-closure to reestablish the protective epithelial barrier and ensure long-term tissue homeostasis.

Molecular Structure

Key Protein Components

Hemidesmosomes are composed of several key protein components that span the plasma membrane, form intracellular plaques, and interact with the and . These include transmembrane receptors, cytoplasmic plaque proteins, and accessory molecules that ensure stable adhesion. The primary transmembrane proteins are the α6β4 and BP180 (also known as XVII). The α6β4 functions as the main receptor for laminin-332 in the , forming a non-covalent heterodimer consisting of the α6 and β4 subunits, where the β4 subunit features a large cytoplasmic domain exceeding 1,000 residues that includes four fibronectin type III (FnIII) domains. This cytoplasmic tail of β4 interacts directly with plectin isoform 1a via its FnIII-1 and FnIII-2 domains and with BP230 via the connecting segment and FnIII-3 and FnIII-4 domains, facilitating linkage to the . BP180 is a type II transmembrane that assembles as a homotrimer, characterized by a short globular intracellular domain, a transmembrane , and an extracellular region containing 15 collagenous domains that enable weak binding to laminin-332. Its cytoplasmic N-terminal domain associates with plectin, BP230, and the β4 tail, contributing to plaque stabilization. Plaque proteins, located on the cytoplasmic side, include BP230 (bullous pemphigoid antigen 1, isoform e) and plectin, which act as cytolinkers bridging the transmembrane components to intermediate filaments. BP230 is a 230 kDa plakin family member with a 140-nm coiled-coil rod domain flanked by an N-terminal plakin domain and a C-terminal region containing two plectin repeat domains; it binds the α6β4 integrin's connecting segment and FnIII-3,4 domains, as well as the intracellular domain of BP180 and keratin filaments K5/K14, and exists primarily as a monomer that may heterodimerize with plectin. Plectin, particularly isoform 1a, is a large 500 kDa intermediate filament-associated protein featuring a 200-nm coiled-coil rod, an N-terminal actin-binding domain, and a C-terminal with six plectin repeat domains; it links to the β4 integrin's FnIII-1,2 domains via its actin-binding domain and to keratin filaments K5/K14 through its C-terminus, with a dimeric structure that can oligomerize into tetramers or polymers. Accessory proteins such as CD151 and laminin-332 provide additional stability and binding. CD151, a with four transmembrane domains and small/large extracellular loops, stabilizes the α6β4 by binding the α6 subunit via its large extracellular loop and exists as a within larger complexes. Laminin-332 serves as the key extracellular , forming a cross-shaped heterotrimer of α3, β3, and γ2 chains (approximately 460 kDa in its precursor form) that is synthesized by and binds both the α6β4 and the extracellular domain of BP180, thereby anchoring the hemidesmosome to the .

Architectural Organization

Hemidesmosomes are organized in a tripartite architecture that spans the , plasma membrane, and intracellular cytoplasm, ensuring stable epithelial attachment to the . The extracellular domain features anchoring filaments, primarily laminin-332, which bind to the extracellular portion of the α6β4 , forming initial adhesions within the lamina lucida of the . The transmembrane core consists of the α6β4 and BP180 (also known as collagen XVII or BPAG2), which traverse the and connect the extracellular anchors to the cytoplasmic plaque, with the CD151 stabilizing lateral associations at the membrane interface. Intracellularly, the plaque is a dense, multiprotein assembly where the cytoplasmic tails of α6β4 recruit plectin and BP230 (BPAG1), which in turn form attachments to intermediate filaments (K5/K14), providing a hierarchical link to the . Under electron , hemidesmosomes appear as half-desmosome structures, characterized by electron-dense plaques on the cytoplasmic side of the basal plasma , often described as rivet-like to emphasize their role in tissue anchorage. These plaques measure approximately 0.5 μm in diameter and exhibit a substructure with an outer plaque adjacent to the —containing tails and BP180 N-termini—and an inner plaque further cytoplasmically, where plectin and BP230 densities are prominent, separated by a less electron-dense zone. High-resolution techniques, such as , reveal precise spatial arrangements, with BP230 forming a central core surrounded by BP180 at distances of about 55 nm, and plectin positioning asymmetrically between the and filaments (56-68 nm apart). Hemidesmosomes exist in two main subtypes distinguished by their protein composition and tissue distribution. Type I, the classic form found in stratified epithelia such as the , incorporates the full complement of core proteins including α6β4 , BP180, plectin, and BP230, resulting in a robust, multi-layered plaque. In contrast, Type II hemidesmosomes, observed in simple epithelia such as the intestinal mucosa, lack BP230 and often BP180, relying primarily on α6β4 and plectin for a more streamlined organization and attachment.

Assembly and Dynamics

Formation Process

The formation of hemidesmosomes begins with the clustering of the α6β4 integrin at the basal plasma membrane of epithelial cells upon contact with laminin-332 in the , initiating the assembly process during cell differentiation. This binding stabilizes the integrin and promotes its lateral clustering, which is essential for recruiting intracellular components. Subsequent recruitment occurs sequentially via the cytoplasmic tails of the β4 integrin subunit. Plectin isoform 1a first binds to the type III (FnIII) repeats and C-terminal region of β4, forming a stable complex that anchors to the . BP180 (also known as BPAG2 or type XVII ) then associates with this complex through interactions with plectin's plakin domain and β4's FnIII-3 repeat, further stabilizing the structure. Finally, BP230 (BPAG1e) is recruited via binding to BP180 and additional sites on β4's FnIII-3/4 repeats, completing the plaque formation and providing initial stabilization. Maturation involves the integration of hemidesmosomes with intermediate filaments, such as K5/K14 in epidermal cells, to achieve full mechanical anchorage. Plectin and BP230 serve as linkers, bundling and attaching these filaments to the plaque, which enhances stability and load-bearing capacity. , particularly through the RhoA-ROCK pathway activated by guanine exchange factors like Solo (ARHGEF40), play a key role in this cytoskeletal linkage by reorganizing filaments and promoting plaque maturation in response to mechanical forces. In embryonic development, hemidesmosomes first appear in basal epithelial cells shortly after , coinciding with the establishment of stratified epithelia. In , α6 integrin clusters emerge around 2.5 days post-fertilization, with mature hemidesmosomes visible by 4.5 days as intermediate filaments integrate. In mammals, such as mice and humans, initial plaques form during mid-, around embryonic day 13.5 in mice or 9 weeks gestation in humans, maturing by 15 weeks to support tissue integrity.

Regulation and Turnover

The stability and turnover of hemidesmosomes are tightly regulated by post-translational modifications and environmental signals to maintain epithelial integrity while allowing dynamic remodeling during processes such as . In steady-state epithelia, key components like the α6β4 integrin exhibit biological half-lives of approximately 42-45 hours, reflecting a relatively slow turnover rate that supports long-term . However, this turnover accelerates significantly in response to wounding, where hemidesmosomal s dissolve within 24 hours to facilitate epithelial cell into the provisional matrix. Phosphorylation events play a central role in promoting hemidesmosome disassembly, particularly through (PKC)-mediated modifications of the β4 integrin cytoplasmic tail. For instance, phosphorylates β4 at residues such as Ser1424, Ser1356, Ser1364, and Thr1736, often triggered by growth factors like EGF via downstream kinases including ERK1/2 and p90RSK, which disrupts interactions with plectin and initiates and turnover of the . Similarly, phosphorylation of BP180 contributes to its redistribution away from hemidesmosomes, further destabilizing the complex during migratory states. Proteolytic cleavage by proteases and matrix metalloproteinases (MMPs) also governs hemidesmosome turnover by targeting extracellular and transmembrane components. ADAM10 and ADAM17 shed the ectodomain of BP180, generating a 120-kDa fragment that promotes keratinocyte detachment and hemidesmosome disassembly, thereby balancing with epithelial turnover. MMPs, in turn, process laminin-332 by cleaving its α3 and γ2 chains, which not only facilitates basement membrane integration but also enables the release of bioactive fragments that signal for hemidesmosome remodeling during tissue repair. Environmental cues, such as calcium levels, modulate hemidesmosome dynamics through calcium-dependent proteases and binding proteins. Elevated extracellular calcium induces differentiation and hemidesmosome disassembly via binding to plectin's actin-binding domain, preventing its re-association with β4 , while calpains proteolytically degrade β4 and plectin to accelerate turnover. These mechanisms are particularly evident during epithelial-mesenchymal transition (EMT), where hemidesmosome disassembly, driven by and , supports enhanced cell motility in and pathological invasion.

Functions

Adhesion and Mechanical Support

Hemidesmosomes serve as critical anchors that transmit tensile forces from the basal epithelial cells to the underlying , primarily through the linkage of integrin α6β4 to intermediate filaments. This connection enables the junctions to withstand mechanical stresses encountered during tissue deformation, ensuring stable adhesion under physiological loads. The integrin α6β4 binds with high affinity to laminin-332 in the , forming a robust interface that supports force distribution across the epithelial layer. In terms of load-bearing capacity, hemidesmosomes effectively resist actomyosin-generated cellular tension by mechanically coupling with focal adhesions, thereby modulating overall traction forces. Studies using micropillar arrays have demonstrated that proficient in hemidesmosomal components, such as β4 , generate significantly lower traction forces—approximately 137 nN per cell—compared to β4-deficient cells, which exert up to 365 nN, highlighting the junctions' role in load sharing and force dissipation. This capacity allows hemidesmosomes to endure shear stresses inherent to epithelial environments, contributing to the structural integrity of tissues subjected to repetitive mechanical challenges. The mechanical support provided by hemidesmosomes is particularly vital for tissue resilience in high-friction areas, such as the soles of the feet, where constant shear and pressure could otherwise lead to detachment and blistering. Defects in hemidesmosomal components, as seen in junctional , result in fragile that blisters precisely in these friction-prone regions due to impaired force transmission and stability. By preventing such epithelial-basement membrane separation, hemidesmosomes maintain overall tissue durability and protect against mechanical trauma in load-bearing epithelial contexts.

Signaling Roles

Hemidesmosomes serve as dynamic signaling platforms where the integrin α6β4, a core component, transduces signals that influence epithelial cell survival and proliferation. Ligation of α6β4 activates the PI3K pathway through of adaptor proteins such as IRS-1 and IRS-2, leading to downstream activation of Akt, which promotes anti-apoptotic effects and enhanced cell adhesion in . Additionally, β4 cytoplasmic tail recruits signaling molecules that stimulate the MAPK/ERK pathway, contributing to proliferative responses while maintaining hemidesmosomal integrity under steady-state conditions. These pathways highlight α6β4's role beyond mechanical anchorage, integrating extracellular cues to regulate cell fate. Plectin, another key hemidesmosomal protein, facilitates signaling crosstalk that establishes and maintains apical-basal polarity in epithelial cells. By linking α6β4 to the network, plectin ensures polarized distribution of cellular components during epithelial . This scaffolding function also influences differentiation programs, as plectin stabilization correlates with hemidesmosome maturation in basal , while its dysregulation disrupts polarity cues and impairs stratified formation. During processes requiring epithelial motility, such as wound repair, hemidesmosomes undergo regulated disassembly to enable migration, mediated by Src family kinases. Activation of the EGF receptor recruits Fyn kinase to α6β4, resulting in phosphorylation of the β4 tail, which destabilizes hemidesmosomal associations and redirects signaling toward promigratory outputs. Similarly, EGF-induced MAPK signaling β4 at serine residues (e.g., Ser1424 and Ser1427), inhibiting new hemidesmosome assembly and facilitating transient cytoskeletal reorganization for collective cell movement. This disassembly is reversible, allowing hemidesmosome reformation post-migration to restore tissue integrity.

Comparisons with Other Cell Junctions

Differences from Desmosomes

Hemidesmosomes and desmosomes, while both serving as anchoring junctions that link to keratin intermediate filaments, differ fundamentally in their architecture and adhesive roles. Hemidesmosomes form asymmetric structures at the basal surface of epithelial cells, connecting the plasma membrane to the underlying basement membrane in a unidirectional manner. In contrast, desmosomes are symmetric, spanning the intercellular space to mediate adhesion between adjacent cells along lateral membranes. At the molecular level, hemidesmosomes rely on integrin α6β4 as the key transmembrane receptor, which binds extracellularly to laminin-332 in the and intracellularly anchors to an electron-dense plaque composed primarily of plectin and BPAG1e (also known as BP230). Desmosomes, however, employ calcium-dependent cadherins—such as desmogleins and desmocollins—that extend across the intercellular gap and connect to a plaque rich in desmoplakin, proteins like plakoglobin and plakophilin, and other components that facilitate symmetric linkage. Both junction types associate with filaments (e.g., K5/K14 in epithelia), but hemidesmosomes direct these filaments toward the for matrix anchorage, whereas desmosomes bundle and interlink keratins between neighboring cells to span the adhesive interface. Functionally, hemidesmosomes provide stable basal anchorage essential for maintaining epithelial integrity against vertical tensile forces, and their disassembly is a critical regulatory step during epithelial-mesenchymal transition (EMT), allowing cells to detach from the matrix and acquire migratory properties in processes like wound healing or development. Desmosomes, by comparison, ensure lateral cohesion within epithelial sheets, conferring resistance to shear and frictional stresses encountered in mechanically demanding tissues such as the epidermis or heart. These distinctions underscore hemidesmosomes' specialization in cell-extracellular matrix interactions versus desmosomes' role in intercellular mechanical coupling.

Relation to Focal Adhesions

Hemidesmosomes and focal adhesions are both specialized cell-extracellular matrix (ECM) adhesion structures that mediate attachment to the and underlying , primarily through receptors. In hemidesmosomes, the α6β4 binds laminin-332 in the ECM, facilitating stable epithelial anchorage, while focal adhesions employ β1 integrins, such as α3β1 and α5β1, to engage various ECM components like and . Both structures resist mechanical forces generated by cellular contractility, with hemidesmosomes countering actomyosin tension via intermediate filaments to maintain tissue integrity, akin to how focal adhesions transduce forces through linkages to regulate cellular tension and mechanosensing. Key differences arise in their cytoskeletal integrations and dynamics, reflecting their roles in distinct cellular contexts. Hemidesmosomes link the plasma membrane to filaments via intracellular proteins like plectin and BP230, forming large, stable plaque-like assemblies that provide tensile strength for long-term in stratified epithelia. In contrast, focal adhesions connect to the dynamic through adaptors such as and paxillin, enabling rapid assembly and disassembly to support and contractility. This distinction underscores hemidesmosomes' emphasis on enduring structural support versus the contractile, motile functions of focal adhesions. Crosstalk between these adhesions is evident during epithelial remodeling, such as in or invasion, where hemidesmosome disassembly promotes formation and turnover. Loss of α6β4-mediated hemidesmosomes increases traction forces and enhances dynamics by elevating free diffusion and FAK signaling, facilitating a shift to migratory . Plectin serves as a mechanical coupler, linking to and modulating force transmission between the two structures.

Associated Diseases

Epidermolysis Bullosa Variants

(EB) encompasses a group of inherited skin fragility disorders, with variants arising from defects in hemidesmosome components that disrupt between the and , including junctional EB (JEB) and some forms of (EBS). These genetic mutations lead to cleavage within or above the lamina lucida of the zone, resulting in widespread blistering and tissue fragility upon minor trauma. Most forms are autosomal recessive in , requiring biallelic pathogenic variants for manifestation. The Herlitz variant of JEB (JEB-Herlitz) is the most severe form, characterized by complete absence of functional hemidesmosomes due to mutations in genes encoding laminin-332, a crucial for hemidesmosomal . Pathogenic variants in LAMA3, LAMB3, or LAMC2 genes, which code for the α3, β3, and γ2 chains of laminin-332, respectively, abolish stable anchoring and often introduce premature termination codons leading to null alleles. This results in profound loss of epidermal-dermal adhesion, manifesting as extensive erosions and blistering at birth that are lethal in early infancy without intensive care, accompanied by exuberant in mucous membranes and nail loss. Non-Herlitz JEB, including intermediate and localized forms, arises from milder in the laminin-332 genes or in COL17A1, encoding BPAG2 (type XVII ), a transmembrane hemidesmosome component. These variants lead to partial hemidesmosome function, resulting in less severe blistering typically starting in childhood, with prominent nail , dental enamel defects, and scarring, but improved survival compared to Herlitz JEB. JEB variants can also stem from mutations in ITGA6 or ITGB4, encoding the integrin α6β4 transmembrane receptor within hemidesmosomes, which links the to laminin-332 in the . Biallelic variants disrupt hemidesmosome assembly, causing skin blistering; in some cases, this manifests as JEB with pyloric atresia (JEB-PA), featuring gastrointestinal malformations such as pyloric atresia presenting with and obstruction shortly after birth, often requiring surgical intervention. JEB due to α6β4 defects may lack PA, presenting with generalized or localized blistering and potential renal anomalies. Additional complications in severe cases include , contributing to high mortality rates. Mutations in genes encoding intracellular hemidesmosome plaque proteins, such as PLEC (plectin) and DST (BPAG1-e), primarily cause EBS variants with intraepidermal cleavage but hemidesmosome abnormalities. Recessive PLEC mutations lead to EBS with (EBS-MD), characterized by congenital skin blistering, nail dystrophy, and progressive skeletal muscle weakness, often with ; milder skin-only forms also occur. DST mutations cause rare autosomal recessive EBS with mild acral blistering, , and occasional nail involvement, due to deficiency in BPAG1-e. Clinically, JEB and EBS variants feature trauma-induced blisters and erosions starting at birth or in infancy, often involving mucous membranes and leading to chronic wounds, milia formation, and atrophic scarring upon healing. Oral involvement is prominent in JEB, with and dental caries due to disrupted from hemidesmosome defects in developing teeth. Inheritance follows an autosomal recessive pattern in most cases, with carrier parents at 25% risk of recurrence per pregnancy.

Autoimmune Blistering Disorders

Autoimmune blistering disorders involving hemidesmosomes are characterized by the production of autoantibodies that target key structural components of these complexes, leading to subepidermal separation of the skin and s. These conditions, primarily (BP) and (MMP), arise from acquired immune dysregulation rather than genetic defects, resulting in inflammatory blistering through antibody-mediated disruption of the dermal-epidermal junction. Bullous pemphigoid manifests as tense subepidermal blisters, predominantly affecting elderly individuals over 60 years of age, with an incidence rising sharply in those over 80. Pathogenic IgG autoantibodies in BP primarily target BP180 (type XVII collagen) and BP230 (a plakin family protein), both integral hemidesmosomal components that anchor basal keratinocytes to the basement membrane. These IgG antibodies, particularly subclasses IgG1 and IgG4, bind to the extracellular domains of BP180 and BP230, triggering complement activation and subsequent recruitment of inflammatory cells such as eosinophils and neutrophils. Mucous membrane pemphigoid, in contrast, preferentially involves mucosal surfaces such as the oral and genital areas, often leading to scarring and potential complications like . Autoantibodies in MMP commonly target the NC16A domain of BP180, a membrane-proximal non-collagenous region critical for hemidesmosomal stability, with reactivity detected in approximately 50% of cases via standard assays. This domain-specific targeting disrupts adhesion at the zone, promoting chronic inflammation and fibrotic scarring in affected mucosae. In both disorders, the binding of autoantibodies to hemidesmosomal antigens like BP180 impairs the clustering and function of α6β4 , which are essential for stable anchorage to the . This disruption activates complement and proteases such as MMP-9 and , which degrade hemidesmosomal proteins and the underlying , culminating in dermo-epidermal separation and inflammatory formation. The resulting influx of and other leukocytes amplifies tissue damage through release and further proteolytic activity.

Research Developments

Historical Discovery

The initial observation of hemidesmosomes occurred in the mid-1950s through electron microscopy studies of mammalian epidermis. In 1955, Cecily C. Selby described dense rod-like structures along the basal plasma membrane of epidermal cells at the dermo-epidermal junction, where tonofilaments terminated, terming them "half-desmosomes" due to their resemblance to one side of intercellular desmosomes. These structures were further characterized in 1958 by George F. Odland, who identified them as "attachment plaques" in human forearm epidermis, noting their regular spacing, association with tonofibrils, and role in anchoring basal cells to the underlying dermis via a thin extracellular layer. This ultrastructural work established hemidesmosomes as specialized adhesion sites distinct from desmosomes, providing the foundational morphological framework for subsequent molecular investigations. During the 1970s and 1980s, research on autoimmune blistering disorders revealed key antigenic components of hemidesmosomes. In 1981, John R. Stanley and colleagues identified the 230-kDa (BPAG1), a hemidesmosomal plaque protein recognized by autoantibodies in patients, confirming its localization to the basal and its role in linking intermediate filaments to the membrane. Shortly thereafter, in the late 1980s, a second , the 180-kDa BPAG2 (also known as type XVII ), was characterized as a transmembrane hemidesmosomal component targeted by autoantibodies, with its extracellular collagenous domain implicated in adhesion to the and its association with subepidermal blistering in autoimmune diseases. These discoveries linked hemidesmosomal integrity to pathogenic , shifting focus from pure morphology to . A pivotal milestone came in 1990 with the cloning of the α6β4 , establishing it as a core transmembrane component of hemidesmosomes. Frans Hogervorst and colleagues sequenced the β4 subunit cDNA, revealing a large cytoplasmic domain unique among , which interacts with intracellular plaque proteins like BPAG1 to anchor filaments, while the extracellular domain binds in the . This molecular identification provided the essential framework for understanding hemidesmosomes as integrin-mediated adhesion complexes, bridging early ultrastructural observations with the emerging field of cell-matrix interactions.

Recent Advances

Recent research in the has elucidated the hemidesmosome's role in modulating cellular mechanics, particularly through interactions with focal adhesions. A 2020 study in demonstrated that hemidesmosomes resist actomyosin-generated tension by mechanically coupling with focal adhesions, limiting their assembly and reducing traction forces; disruption of this crosstalk leads to increased cell spreading and force generation. In the (RPE), chronic subtoxic induces polarized shedding of hemidesmosomes via small extracellular vesicles, serving as an early indicator of outer blood-retina barrier dysfunction and contributing to age-related (AMD) progression. In early AMD, hemidesmosome disassembly under disrupts RPE polarity and adhesion, promoting epithelial-mesenchymal transition (EMT)-like changes that exacerbate disease advancement, as highlighted in 2023 analyses. Beyond epithelial tissues, hemidesmosomes have been implicated in non-skin pathologies. In oral , alterations in expression levels of hemidesmosomal components, such as α6 and β4, facilitate EMT modulation and tumor invasion, positioning these structures as potential biomarkers for pre-cancerous lesions and . Therapeutic advancements targeting hemidesmosome-related disorders have gained momentum by 2025. Preclinical studies for junctional (JEB) employ / to correct mutations in laminin-332 genes like LAMB3, restoring functional protein expression and in patient-derived cells, with data showing laminin-332 deposition up to ~50% of wild-type levels in 3D models after 2 weeks. Additionally, gene replacement therapies using retroviral vectors to deliver functional LAMB3 have advanced to clinical trials, with Phase I/II studies demonstrating safety and partial restoration of integrity in JEB patients as of the early .

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC4544487/
  2. https://www.cell.com/trends/cell-biology/fulltext/S0962-8924(06)00139-5
  3. https://www.sciencedirect.com/science/article/pii/S0022202X15404427
  4. https://journals.biologists.com/jcs/article/134/18/jcs259004/272177/Regulation-of-hemidesmosome-dynamics-and-cell
  5. https://rupress.org/jcb/article/219/2/e201904137/133567/Hemidesmosomes-modulate-force-generation-via-focal
  6. https://link.springer.com/article/10.1007/s00441-014-2061-z
  7. https://www.sciencedirect.com/topics/neuroscience/hemidesmosome
  8. https://vmicro.iusm.iu.edu/hs_vm/docs/glossary.pdf
  9. https://pubmed.ncbi.nlm.nih.gov/9010784/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3955972/
  11. https://journals.biologists.com/jcs/article/128/20/3714/55258/The-molecular-architecture-of-hemidesmosomes-as
  12. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0195124
  13. https://anatomypubs.onlinelibrary.wiley.com/doi/10.1002/dvdy.22255
  14. https://academic.oup.com/carcin/article/21/2/325/2896350
  15. https://www.liebertpub.com/doi/10.1089/wound.2013.0436
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC7041674/
  17. https://pubmed.ncbi.nlm.nih.gov/10379703/
  18. https://www.jidonline.org/article/S0022-202X(15)30952-0/fulltext
  19. https://www.jbc.org/article/S0021-9258(20)46740-7/fulltext
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC2150849/
  21. https://pubmed.ncbi.nlm.nih.gov/8666164/
  22. https://www.sciencedirect.com/science/article/abs/pii/S0955067405800055
  23. https://www.nature.com/articles/s41580-020-0237-9
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC5453391/
  25. https://www.sciencedirect.com/science/article/pii/S0005273607002751
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC4492441/
  27. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.886569/full
  28. https://www.ncbi.nlm.nih.gov/books/NBK1125/
  29. https://pubmed.ncbi.nlm.nih.gov/9326326/
  30. https://www.ncbi.nlm.nih.gov/books/NBK1157/
  31. https://www.ncbi.nlm.nih.gov/books/NBK1369/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC1070439/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC8652395/
  34. https://pubmed.ncbi.nlm.nih.gov/32048350/
  35. https://pubmed.ncbi.nlm.nih.gov/19755944/
  36. https://pubmed.ncbi.nlm.nih.gov/38946225/
  37. https://rupress.org/jcb/article-pdf/1/5/429/1069789/429.pdf
  38. https://pubmed.ncbi.nlm.nih.gov/13587545/
  39. https://pubmed.ncbi.nlm.nih.gov/7018697/
  40. https://pubmed.ncbi.nlm.nih.gov/2311578/
  41. https://pubmed.ncbi.nlm.nih.gov/38108061/
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC10177336/
  43. https://www.sciencedirect.com/science/article/pii/S2667026724000912
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC10889532/
Add your contribution
Related Hubs
User Avatar
No comments yet.